Huimin Geng Selected Research

E2A-Pbx1 fusion protein

1/2020

E2A-PBX1 functions as a coactivator for RUNX1 in acute lymphoblastic leukemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Huimin Geng Research Topics

Disease

18	Neoplasms (Cancer) 07/2022 - 02/2010
11	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 11/2021 - 10/2011
11	Leukemia 11/2021 - 11/2012
8	Lymphoma (Lymphomas) 10/2021 - 02/2010
4	Precursor B-Cell Lymphoblastic Leukemia-Lymphoma (Leukemia, Pre B Cell) 01/2017 - 03/2013
3	Genetic Translocation (Chromosomal Translocation) 01/2020 - 01/2013
2	Residual Neoplasm 01/2020 - 03/2013
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 10/2018 - 12/2010
2	B-Cell Lymphoma (Lymphoma, B Cell) 01/2016 - 08/2013
2	Philadelphia Chromosome 05/2015 - 01/2015
1	Breast Neoplasms (Breast Cancer) 07/2022
1	Hemorrhage 02/2020
1	Multiple Myeloma 01/2020
1	B-Cell Leukemia (Leukemia, B Cell) 01/2020
1	Acute Promyelocytic Leukemia 10/2018
1	Burkitt Lymphoma (Burkitt's Lymphoma) 01/2018
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2017
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2015
1	Carcinoma (Carcinomatosis) 08/2013
1	Carcinogenesis 04/2011
1	Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated) 02/2010
1	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 02/2010
1	T-Cell Lymphoma (Lymphoma, T Cell) 02/2010
1	Prostatic Neoplasms (Prostate Cancer) 12/2006

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 01/2020 - 01/2013
4	Biomarkers (Surrogate Marker)IBA 10/2021 - 12/2006
3	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 04/2011
3	Pre-B Cell ReceptorsIBA 04/2016 - 08/2013
2	Lactic Acid (Lactate)FDA LinkGeneric 10/2021 - 10/2018
2	Phosphotransferases (Kinase)IBA 01/2021 - 01/2015
2	MethyltransferasesIBA 01/2020 - 01/2020
2	Lenalidomide (CC 5013)FDA Link 01/2019 - 10/2018
2	Oncogene Proteins (Oncogene Protein)IBA 11/2018 - 11/2012
2	Pharmaceutical PreparationsIBA 10/2018 - 03/2013
2	Glucose (Dextrose)FDA LinkGeneric 01/2018 - 01/2017
2	CytosineIBA 01/2013 - 11/2012
1	ChemokinesIBA 11/2021
1	Galectin 3 (LGALS3)IBA 11/2021
1	gamma-Aminobutyric Acid (GABA)IBA 10/2021
1	Neurotransmitter Agents (Neurotransmitter)IBA 10/2021
1	UbiquitinIBA 01/2021
1	Glycoproteins (Glycoprotein)IBA 01/2021
1	Hydroxyethyl Starch Derivatives (Pentastarch)FDA Link 01/2021
1	Chimeric Antigen ReceptorsIBA 01/2021
1	Single-Domain AntibodiesIBA 01/2021
1	Co-Repressor ProteinsIBA 12/2020
1	A-factor (Streptomyces)IBA 10/2020
1	HydrogelsIBA 02/2020
1	IntegrinsIBA 01/2020
1	E2A-Pbx1 fusion proteinIBA 01/2020
1	daratumumabIBA 01/2020
1	Lysine (L-Lysine)FDA Link 01/2020
1	Retinoic Acid Receptors (Retinoic Acid Receptor)IBA 10/2018
1	Dihydrotachysterol (AT 10)IBA 10/2018
1	Methotrexate (Mexate)FDA LinkGeneric 10/2018
1	DioxygenasesIBA 10/2018
1	Rituximab (Mabthera)FDA Link 10/2018
1	Threonine (L-Threonine)FDA Link 01/2018
1	AntibodiesIBA 01/2018
1	Serine (L-Serine)FDA Link 01/2018
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2018
1	CarbonIBA 01/2018
1	Protein Phosphatase 2 (Protein Phosphatase 2A)IBA 01/2018
1	ChromatinIBA 01/2017
1	Adenosine Triphosphate (ATP)IBA 01/2017
1	Biological ProductsIBA 01/2017
1	GlucocorticoidsIBA 01/2017
1	Histones (Histone)IBA 01/2017
1	TensinsIBA 04/2016
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 04/2016
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 04/2016
1	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 04/2016
1	venetoclaxIBA 12/2015
1	CytokinesIBA 07/2015
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 05/2015
1	Phenylalanine (L-Phenylalanine)FDA Link 08/2013
1	Peptides (Polypeptides)IBA 08/2013
1	Monoclonal AntibodiesIBA 06/2013
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 06/2013
1	Tyrosine Kinase InhibitorsIBA 06/2013
1	Imatinib Mesylate (Gleevec)FDA Link 06/2013
1	nilotinib FDA Link 03/2013
1	Integrin alpha4IBA 03/2013
1	Natalizumab (Tysabri)FDA Link 03/2013
1	Immunoglobulin Light Chains (Immunoglobulin Light Chain)IBA 10/2011
1	Small Interfering RNA (siRNA)IBA 12/2010
1	Anaplastic Lymphoma KinaseIBA 02/2010

Therapy/Procedure

9	Therapeutics 01/2019 - 02/2010
3	Drug Therapy (Chemotherapy) 11/2021 - 03/2013
1	Lasers (Laser) 07/2022
1	Immunotherapy 01/2021
1	Biological Therapy 10/2018